Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Looking for low annual fee credit cards for travel? Explore options to save money and enhance your travel experience.
18,244 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Analysts say the global economy is entering the largest capex cycle on record, fueled by energy transition and surgin...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
A U.S. electronics maker and a Chinese supplier are reshaping their supplier networks to weather tariff shocks and ge...
A viral claim has sparked headlines: a bitcoin owner claims claude helped recover a lost wallet and netted $400K in B...
Lucid fans and skeptics watched the Gravity SUV as a potential turning point. When production snags and a rear-seat r...
A single AI stock could outperform the rest on Nasdaq by the end of 2026. This article breaks down why that might hap...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
Insider moves can signal confidence, but they aren’t a surebet. This guide shows you how to interpret a director purc...
A Warby Parker director recently sold 25,000 shares, triggering questions about insider moves. This article breaks do...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...